Kim-Arthur Baffert

Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients

Jean‐Philippe Foy, Andy Karabajakian, Sandra Ortiz‐Cuaran et al. · European Journal of Cancer · 2022 · 62 citations

Cancer Immunosurveillance, Medicine, Immunology +10

Quality of Life of Patients With Cancer During the COVID-19 Pandemic

Kim-Arthur Baffert, Tiffany Darbas, Valérie Lebrun-Ly et al. · In Vivo · 2021 · 43 citations · Full text

Datasets for gene expression profiles of head and neck squamous cell carcinoma and lung cancer treated or not by PD1/PD-L1 inhibitors

Jean‐Philippe Foy, Andy Karabajakian, Sandra Ortiz‐Cuaran et al. · Data in Brief · 2022 · 18 citations · Full text

Engineering, Oncogenic Agent, Medicine +10

Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial

Elise Bonnet, Véronique Haddad, Stanislas Quesada et al. · Journal of Personalized Medicine · 2022 · 12 citations · Full text

Renin-Angiotensin-System Inhibitors for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: OncoToxSRA, a Preliminary Cohort Study

Simon Frachet, Aurore Danigo, Marc Labriffe et al. · Journal of Clinical Medicine · 2022 · 11 citations · Full text

Chemoprevention Strategy, Neuropathic Pain, Pharmacotherapy +19